4//SEC Filing
Ginascol John F 4
Accession 0001415889-22-001738
CIK 0000001800other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 8:15 PM ET
Size
7.4 KB
Accession
0001415889-22-001738
Insider Transaction Report
Form 4
Ginascol John F
Executive Vice President
Transactions
- Award
Common shares without par value
2022-02-18+17,247→ 130,921 total - Award
Option (right to buy)
2022-02-18+80,380→ 80,380 totalExercise: $117.58From: 2023-02-18Exp: 2032-02-17→ Common Shares (80,380 underlying)
Footnotes (2)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 26,793 on February 18, 2023, 26,793 on February 18, 2024, and 26,794 on February 18, 2025.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001778075
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 8:15 PM ET
- Size
- 7.4 KB